KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has agreed to acquire KalVista Pharmaceuticals, a pharmacy business in Massachusetts, for $27.00 per share in cash, as part of a going private acquisition. KalVista Pharmaceuticals develops specialty medicines for patients with serious conditions, supporting Chiesi Farmaceutici’s pharmacy acquisition strategy in healthcare M&A. Chiesi Farmaceutici acquisitions aim to expand its portfolio through MA acquisitions centered on KalVista Pharmaceuticals acquisition in the United States. The strategic acquisition is structured as a wholly owned subsidiary tender offer under SEC Schedule TO, with the going private acquisition valued at over $100M and expected to close subject to customary conditions.